Efficacious nanomedicine track toward combating COVID-19-Reference-Cited by-同舟云学术

Efficacious nanomedicine track toward combating COVID-19

Published:2022-01-01 Issue:1 Volume:11 Page:680-698
ISSN:2191-9097
Container-title:Nanotechnology Reviews
language:en
Short-container-title:

Author:

Mohammed Sameh A.¹²,Shaaban Esraa Ibrahim A.³⁴

Affiliation:

1. Department of Micro-Nano Mechanical Science and Engineering, Graduate School of Engineering, Nagoya University , Nagoya , Japan

2. Department of Pharmacology and Toxicology, Faculty of Pharmacy, Beni-Suef University , Beni-Suef , Egypt

3. Department of Biochemistry, Graduate School of Medical Sciences, Nagoya City University , Mizuho-cho, Mizuho-ku , Nagoya 467-8601 , Japan

4. Sinoris Medical Center, Community Pharmacy, Fayoum Health Association, Ministry of Health , Fayoum , Egypt

Abstract

Abstract COVID-19 outbreak has become one of the catastrophic health emergencies that could threaten public health worldwide through several hospitalizations and thousands of deaths, leading to boosting global concern intensive precautionary measurements. The clinical and research trials are ongoing for developing several diagnostic tools, antiviral therapeutics, and vaccines versus COVID-19 infectiousness. This review argues the recent nanomedical progress and efficient nanomedicine applications and highlights relevant challenges and considerations of nano-based materials for combating COVID-19 infectiousness and severity. Eventually, we also provide futuristic avenues and perspectives paving the way to explore outstanding solutions for SARS-CoV-2 control and eradication.

Publisher

Walter de Gruyter GmbH

Subject

Surfaces, Coatings and Films,Process Chemistry and Technology,Energy Engineering and Power Technology,Biomaterials,Medicine (miscellaneous),Biotechnology

Link

https://www.degruyter.com/document/doi/10.1515/ntrev-2022-0036/pdf

Reference135 articles.

1. Pal M, Berhanu G, Desalegn C, Kandi V. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): an update. Cureus. 2020;12(3):e7423.

2. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China. N Engl J Med. 2020;382(8):727–33.

3. Chen J, Qi T, Liu L, Ling Y, Qian Z, Li T, et al. Clinical progression of patients with COVID-19 in Shanghai. China. J Infect. 2020;80(5):e1–6.

4. Coronaviridae Study Group of the International Committee on Taxonomy of Viruses. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol. 2020;5(4):536–44.

5. Johansson MA, Quandelacy TM, Kada S, Prasad PV, Steele M, Brooks TJ, et al. SARS-CoV-2 transmission from people without COVID-19 symptoms. JAMA Netw Open. 2021;4(1):e2035057.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Electrochemical capacitance spectroscopy based determination of antibodies against SARS-CoV-2 virus spike protein;Science of The Total Environment;2023-12

2. Smart Magnetic Drug Delivery Systems for the Treatment of Cancer;Nanomaterials;2023-02-26

3. Nanotechnological strategies for drug delivery and treatment of COVID-19;Nanotechnology Principles in Drug Targeting and Diagnosis;2023

4. Nano-sized Metal Oxides and Their use as a Surface Disinfectant Against COVID-19: (Review and Perspective);Oriental Journal Of Chemistry;2022-12-30